Product description

NanoCBD is a formulation containing 16.67 mg/mL cannabidiol (CBD) as active ingredient, in a sub-micron spray applied to the oro-buccal membrane. The CBD is sourced from cannabis (hemp) strains and extracted from plant parts that produce high levels of CBD, but no THC.

IP RIGHTS:
Patent Title: Transmucosal and transdermal delivery systems// NanoCelleJurisdiction: AustraliaApplication number: 2016226280Filing Date: 2nd March 16 Status: Accepted
Patent Title: Transmucosal and transdermal delivery systems// NanoCelleJurisdiction: CanadaApplication number: 2978179Filing Date: 2nd March 16 Status: Filed
Patent Title: Transmucosal and transdermal delivery systems// NanoCelleJurisdiction: EuropeApplication number: 16759418.3Filing Date: 2nd March 16 Status: Under examination
Patent Title: Transmucosal and transdermal delivery systems// NanoCelleJurisdiction: New ZealandApplication number: 735138Filing Date:  2nd March 2016 Status: Examination Requested
Patent Title: Transmucosal and transdermal delivery systems// NanoCelleJurisdiction: SingaporeApplication number: 11201707068XFiling Date: 2nd March 2016 Status: Under examination
Patent Title: Transmucosal and transdermal delivery systems// NanoCelleJurisdiction: United StatesApplication number: 15/555038 Filing Date: 2nd March 2016Status: Under examination
Patent Title: Transmucosal and transdermal delivery systems// NanoCelleJurisdiction: Hong KongApplication number: 18103321.4Filing Date: 2nd March 2016Status: Filed

Patent Title: Protection of plant extracts and compounds from degradation API DegradationMedlab product/subject ref: API DegradationJurisdiction: AustraliaApplication number: 2017261847Filing Date: 11 May 2016Status: Accepted
Patent Title: Protection of plant extracts and compounds from degradation API DegradationMedlab product/subject ref: API DegradationJurisdiction: CanadaApplication number: 3023767Filing Date: 11 May 2016Status: Filed 
Patent Title: Protection of plant extracts and compounds from degradation API DegradationMedlab product/subject ref: API DegradationJurisdiction: EuropeApplication number: 17795190.2Filing Date: 11 May 2016Status: under examination 
Patent Title: Protection of plant extracts and compounds from degradation API DegradationMedlab product/subject ref: API DegradationJurisdiction: New Zealand Application number: 748609Filing Date: 11 May 2016Status:examination requested
Patent Title: Protection of plant extracts and compounds from degradation API DegradationMedlab product/subject ref: API DegradationJurisdiction: SingaporeApplication number: 11201809976PFiling Date: 11 May 2016Status: Under examination
Patent Title: Protection of plant extracts and compounds from degradation API DegradationMedlab product/subject ref: API DegradationJurisdiction: United StatesApplication number: 16/300537Filing Date: 11 May 2016Status: Under examination
Patent Title: Protection of plant extracts and compounds from degradation API DegradationMedlab product/subject ref: API DegradationJurisdiction: Hong KongApplication number: 19122060.7Filing Date: 11 May 2016Status: Filed
Read more

Specifications

Categories Pharmaceutical Machinery & TechnologyBioavailability enhancement; Pharmaceutical PackagingDrug Delivery Systems; Finished Dosage Forms
Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Central/South America

More products from Medlab Clinical LTD

View all our products (10)

Products from other suppliers